Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: Enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-α

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1139-1147

  Tüting, Thomas ^a   Wilson, Cara C ^a   Martin, Dina M ^a   Kasamon, Yvette L ^a   Rowles, Jennifer ^a   Ma, Debora I ^a   Slingluff Jr , Craig L ^b   Wagner, Stephan N ^c   Van Der Bruggen, Pierre ^d   Baar, Joseph ^a   Lotze, Michael T ^a   Storkus, Walter J ^a,e  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COMPLEMENTARY DNA; EPITOPE; GENE PRODUCT; INTERLEUKIN 12; MELANOMA ANTIGEN; PLASMID DNA;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MELANOMA; MONOCYTE; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DNA, COMPLEMENTARY; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-12; LUCIFERASES; MELANOMA; MEMBRANE GLYCOPROTEINS; MONOCYTES; MUTAGENESIS, INSERTIONAL; NEOPLASM PROTEINS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TRANSFECTION; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 2642679384     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Ertl, H. C. J., and Z. Xiang. 1996. Novel vaccine approaches. J. Immunol. 156:3579.
2. Ulmer, J. B., J. C. Sadoff, M. A. Liu. 1996. DNA vaccines. Curr. Opin. Immunol. 8:531.
3. Kumar, V., and E. Sercarz. 1996. Genetic vaccination: the advantages of going naked. Nat. Med 2:857.
4. Pardoll, D. M., and A. M. Beckerleg. Exposing the immunology of naked DNA. Immunity. 3:165.
5. Xiang, Z., and H. C. J. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129.
6. Kim, J. J., V. Ayyavoo, M. L. Bagarazzi, M. A. Chattergoon. K. Dang, B. Wang, J. D. Boyer, and D. B. Weiner. 1997. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:816.
7. Geissler, M., A. Gesien, K. Tokushige, and J. R. Wands. 1997. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine expressing plasmids. J. Immunol. 158:1231.
8. Tsuji, T., K. Hamajima, J. Fukushima, K.-Q. Xin, N. Ishii, I. Aoki, Y. Ishigatsubo, K. Tani, S. Kawamoto, Y. Nina, J. Miyazaki, W. C. Koff, T. Okubo, and K. Okuda. 1997. Enhancement of cell-mediated immunity against HIV-I induced by coinoculation of plasmid-encoded HIV-I antigen with plasmid expressing IL-12. J. Immunol. 158:4008.
9. Boon, T., and P. Van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725.
10. Zhai, Y., J. C. Yang, Y. Kawakami, P. Spiess, S. C. Wadsworth, L. M. Cardoza, L. A. Couture, A. E. Smith, and S. A. Rosenberg. 1996. Antigen-specific tumor vaccines: development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. J. Immunol. 156:700.
11. Conry, R. M., A. F. LoBuglio, F. Loechel, S. E. Moore, L. A. Sumerel, D. L. Barlow, and D. T. Curiel. 1995. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther. 2:59.
12. Wang, M., V. Bronte, P. W. Chen, L. Gritz, D. Panicali, S. A. Rosenberg, and N. P. Restifo. 1995. Active immunotherapy of cancer with a nonreplicating recombinant fowl poxvirus encoding a model tumor-associated antigen. J. Immunol. 154:4685.
13. Chen, P. W., M. Wang, V. Bronte, Y. Zhai, S. A. Rosenberg, and N. P. Restifo. 1996. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J. Immunol. 156:224.
14. Irvine, K. R., R. B. Rao, S. A. Rosenberg, and N. P. Restifo. 1996. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156:238.
15. Restifo, N. P. 1996. The new vaccines: building viruses that elicit antitumor immunity. Curr. Opin. Immunol. 8:658.
16. Wamier, G., M.-T. Duffour, C. Uyttenhove, T. Gajewski, C. Lurquin, H. Haddada, M. Perricaudet, and T. Boon. 1996. Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A. Int. J. Cancer 67:303.
17. Syrengelas, A. D., T. T. Chen, and R. Levy. 1996. DNA immunization induces protective immunity against B-cell lymphoma. Nat. Med. 2:1038.
18. Condon, C., S. C. Watkins, C. M. Celluzzi, K. Thompson, and L. D. Falo. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1122.
19. Corr, M., D. J. Lee, D. A. Carson, and H. Tighe. 1996. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1555.
20. Ulmer, J. B., R. R. Deck, C. M. Dewitt, J. J. Donnelly, and M. A. Liu. 1996. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89:59.
21. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
22. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10.
23. Storkus, W. J., J. Alexander, J. A. Payne, J. R. Dawson, and P. Cresswell. 1989. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc. Natl. Acad. Sci. USA 86:2361.
24. Wilson, C. C., S. A. Kalams, B. M. Wilkes, D. J. Ruhl, F. Gao, B. H. Hahn, I. C. Hanson, K. Luzuriaga, S. Wolinsky, R. Koup, S. P. Buchbinder, R. P. Johnson, and B. D. Walker. 1997. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J. Virol. 7:1256.
25. Zitvogel, L., H. Tahara, P. D. Robbins, W. J. Storkus, S. F. Wolf, M. Gately, and M. T. Lotze. 1994. Construction and characterization of retroviral vectors expressing biologically active human interleukin 12 (IL-12). Hum. Gene Ther. 5:1493.
26. Wagner, S. N., C. Wagner, H. Hofler, M. J. Atkinson, and M. Goos. 1995. Expression cloning of the cDNA encoding a melanoma-associated antigen recognized by HMB-45: identification as melanocyte-specific Pme117 cDNA. Lab. Invest. 73:229.
27. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethe, P, Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489.
28. Van der Bruggen, P., P. C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643.
29. Gaugler, B., B. Van den Eynde, P. Van der Bruggen, P. Romero, J. J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a human melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921.
30. Tjandrawan, T., D. M. Martin, M. J. Maurer, C. Castelli, M. T. Lotze, and W. J. Storkus. 1998. Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTL in vitro. J. Immunother. In press.
31. Skipper, J. C. A., D. J. Kittlesen, R. C. Hendricksen, D. D. Deacon, N. L. Harthun, S. N. Wagner, D F. Hunt, V. H. Engelhardt, and C. L. Slingluff. 1996. Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from pMel-17/gp100. J. Immunol. 157:5027.
32. Zakut, R., S. L. Topalian, Y. Kawakami, M. Mancini, S. Eliyahu, and S. A. Rosenberg. 1993. Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines. Cancer Res. 53:5.
33. Caux, C., C. Dezutter-Damboyant, D. Schmitt, and J. Bancherau. 1992. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258.
34. Romani, N., S. Gruner, D. Brang, E. Kämpgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Gritsch, R. M Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
35. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J. Immunol. 154:5851.
36. Grabbe, S., S. Beissert, T. Schwarz, and R. D. Granstein. 1995. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy ? Immunol. Today 16:116.
37. Young, J. W., and K. Inaba. 1996. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor-immunity. J. Exp. Med. 183:7.
38. Manickan, E., S. Kanangat, R. J. D. Rouse, Z. Yu, and B. T. Rouse. 1997. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J. Leukocyte Biol. 61:125.
39. Boczkowski, D., S. K. Nair, D. Snyder, and E. Gilboa. 1996. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184:465.
40. Brossart, P., A. W. Goldrath, E. A. Butz, S. Martin, and M. J. Bevan. 1997. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158:3270.
41. Alijagic, S., P. Möller, M. Artuc, K. Jurgovsky, B. M. Czarnetzki, and D. Schadendorf. 1995. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur. J. Immunol. 25:3100.
42. Reeves, M. E., R. E. Royal, J. S. Lam, S. A. Rosenberg, and P. Hwu. 1996. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56:5672.
43. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kämpgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class 11 and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
44. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
45. + blood dendritic cells are potent producers of IFN-α in response to in vitro HIV-1 infection. J. Immunol. 152:4649.
46. Svensson, H., A. Johanisson, T. Nikkila, G. V. Alm, and B. Cederblad. 1996. The cell surface phenotype of human natural interferon-a producing cells as determined by flow cytometry. Scand. J. Immunol. 44:164.
47. Trinchieri, G. 1995. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
48. Belardelli, F. 1995. Role of interferons and other cytokines in the regulation of the immune response. APMIS 103:161.
49. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper cells. J. Exp. Med. 185:825.
50. Vijayasaradhi, S., Y. Xu, B. Bouchard, and A. N. Houghton. 1996. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75. J. Cell. Biol. 130:807.
51. + T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J. Exp. Med. 183:1965.
52. Lin, K.-Y., F. G. Guamieri, K. F. Staveley-O'Caroll, H. I. Levitsky, J. T. August, D. M. Pardoll, and T.-C. Wu. 1996. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56:21.
53. Walter, E. R., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1996. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038.
54. + T cell clones form the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus. J. Immunol. 157:4079.